Local pharmaceutical manufacturer targets global market with first shipment
Health & Science
By
David Njaaga
| Sep 22, 2024
A local pharmaceutical manufacturer is set to enhance Kenya’s global presence through new exports.
SQUARE Pharmaceuticals marked a milestone with its first shipment from the Athi River plant on Friday.
The flag-off ceremony included officials from SQUARE Pharmaceuticals Kenya and Export Processing Zones Authority (EPZA) Director Dr. Iruki Kailemia.
The shipment consisted of 5,500 boxes of Angilock tablets, a medication for high blood pressure that combines two ingredients to help control blood pressure levels. Somalia will be the initial destination.
“This achievement reflects our dedication to providing high-quality healthcare solutions,” Kailemia said, noting plans to supply other African and European countries from the plant.
READ MORE
Coffee farmers oppose new payment proposal
US China trade war to drag global economy into recession
Treasury PS blames ballooning debt on costly new constitution
Interpol, FBI probe CBEX scam in Kenya and Nigeria
State taps new team to review Sacco laws
Gen Zs to dominate consumer spending in the next 10 years
Afrexim pushes for Africa trade bloc as protectionism bites
Kenya Airways forced to divert flights over fog
Coffee market experiences low volume as season ends
Push to consolidate small pension schemes gathers pace in reforms
The firm has operated in Kenya since 2004, with its manufacturing facility opening in 2023.
Kailemia said the export will boost confidence in Kenyan-made pharmaceuticals among local healthcare professionals.
'This export demonstrates that local pharmaceuticals can meet international standards,” he added.
The company employs 250 local workers and plans to increase the number to 1,000 as operations grow, with plans for a line of liquid medications and injections.